VIRMA and gastric adenocarcinoma: KIAA1429 has an oncogenic role in various cancers, including HCC [12, 29], and has been proposed as a biomarker for stomach adenocarcinomas as this is closely correlated with immune checkpoint molecules such as PD-L1 [30].